University of Nottingham Trial Examines Inulin for Knee Osteoarthritis

A six-week clinical trial led by researchers at the University of Nottingham reveals that consuming a daily prebiotic fiber supplement called inulin may offer a way to reduce knee osteoarthritis pain, improve grip strength, and decrease pain sensitivity.

In Plain English: The Clinical Takeaway

• What was tested: Daily supplementation with inulin, a natural dietary fiber found in foods such as chicory root and Jerusalem artichokes, versus digital physical therapy and a placebo.
• The primary clinical outcome: Participants taking inulin experienced reductions in joint pain and lowered pain sensitivity.
• Adherence data: Only 3.6% of patients assigned to the inulin-only group dropped out of the study, compared with 21% of those assigned to physical therapy alone.

University of Nottingham Trial Examines Inulin Efficacy in Knee Osteoarthritis

Knee osteoarthritis is a leading source of long-term disability and suffering for hundreds of millions of individuals globally, particularly those in older age groups. The condition progresses as the structures inside the knee, including the cartilage that serves as a buffer between bone ends, suffer from gradual wear and tear. This can lead to pain, stiffness, swelling, and difficulty with everyday activities. Published in the journal Nutrients, the INSPIRE trial investigated whether targeted manipulation of the gut microbiome via the prebiotic inulin could alleviate symptom severity.

Your knee pain might start in your gut — not the gym.A new University of Nottingham clinical trial (published in Nutrients) found that a daily inulin prebiotic supplement (from chicory root) significantly reduced knee osteoarthritis pain in just 6 weeks.The results were… pic.twitter.com/QnV4vSwrAu

— https://x.com/DrKristieLeong/status/2059647085507477564

The six-week randomized controlled study evaluated 117 adults with knee osteoarthritis. Investigators divided the subjects into four distinct study arms: a group receiving only a daily inulin supplement, a group performing only digitally supported physical therapy exercises (PSE), a group receiving both inulin and physical therapy, or a control group receiving a placebo. Investigators observed that both inulin and physical therapy independently reduced knee pain. Participants taking inulin demonstrated better grip strength and reduced pain sensitivity.

Intervention Arm	Sample Size (N)	Primary Observed Effects	Study Dropout Rate
Inulin Supplement Alone	Trial subset	Reduced knee pain, decreased pain sensitivity, improved grip strength	3.6%
Digital Physical Therapy (PSE)	Trial subset	Reduced knee pain	21.0%
Combined Inulin & Physical Therapy	Trial subset	Combined symptom relief	Not specified
Placebo Control	Trial subset	Baseline comparison group	Not specified

Gut Microbiome Mechanisms and the Glucagon-Like Peptide-1 Connection

Inulin is categorized as a prebiotic due to its ability to encourage the growth of specific healthy gut bacteria, rather than by introducing live microbes itself. When bacteria ferment inulin, they produce substances known as short-chain fatty acids (SCFAs). Among the most significant is butyrate, a substance that bolsters the intestinal wall and may affect inflammation as well as biological processes associated with pain. The researchers found that participants taking inulin had increased levels of butyrate. They also noted elevated concentrations of glucagon-like peptide-1 (GLP-1), a gut-derived hormone that manages appetite and blood sugar, which has also been associated with muscle health and the way pain is processed.

“This study raises the exciting possibility that a simple dietary change — adding a fiber supplement to your breakfast or yogurt — could meaningfully reduce pain and improve physical function.”

— Dr. Afroditi Kouraki, lead author of the study from the School of Medicine at the University of Nottingham

While these findings do not confirm that GLP-1 is the direct driver of the observed benefits, they imply a possible link between digestive tract activity and both muscle performance and pain. Senior author Professor Ana Valdes from the School of Medicine added that the link observed between GLP-1 and grip strength points to a broader gut-muscle-pain axis that warrants further investigation. The findings are promising, but the trial was relatively small and lasted only six weeks. Larger studies will be needed to establish whether the benefits persist.

Public Health Perspectives on Arthritis and Patient Adherence

The potential significance of these findings becomes more apparent when considering the prevalence of ongoing arthritis pain. Professor Lucy Donaldson, Director of Research at Arthritis UK, noted that a recent lived experience survey indicated that six in ten people suffer from pain for most or all of their time because of their arthritis. In this light, the variation in treatment completion rates—with a dropout rate of just 3.6% for those taking inulin compared to 21% for the physical therapy group—indicates that consuming a daily fiber supplement might be simpler to maintain as a habit than adhering to a formal exercise regimen.

“Our recent lived experience survey showed that six in ten people are living in pain most or all of the time due to their arthritis. Researchers are starting to explore the role of the gut microbiome in our experience of pain.”

— Professor Lucy Donaldson, Director of Research at Arthritis UK

The results do not suggest that fiber supplements should replace exercise or other established arthritis treatments. Instead, they point toward a potentially useful additional approach that could complement existing care.

More on University: Wageningen University tests vegan diets on Older Adults · University of Surrey study finds breast cancer screening inequalities · University of Liverpool study finds diet drinks match water for weight loss

References

• Nutrients: Clinical trial findings on inulin supplementation in knee osteoarthritis (INSPIRE Trial, University of Nottingham).
• Arthritis UK: Lived experience surveys on chronic musculoskeletal pain prevalence.
• University of Nottingham School of Medicine: Microbiome fermentation metabolites, short-chain fatty acids, and GLP-1 association studies.